BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 72598)

  • 1. Surface antigenic characteristics of human glial brain tumor cells.
    Wikstrand CJ; Mahaley MS; Bigner DD
    Cancer Res; 1977 Dec; 37(12):4267-75. PubMed ID: 72598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
    Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
    Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
    de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP
    Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glioma-associated antigens detected by monoclonal antibodies.
    Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N
    Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.
    Seeger RC; Rosenblatt HM; Imai K; Ferrone S
    Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
    Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
    Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
    Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
    Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of human brain antiserum with neuroblastoma cells and nonreactivity with thymocytes and lymphoblasts.
    Casper JT; Borella L; Sen L
    Cancer Res; 1977 Jun; 37(6):1750-6. PubMed ID: 66986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
    Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-tumor antibodies in the blood of patients with gliomas].
    Martin-Achard A; Diserens AC; de Tribolet N; Zander E; Carrel S
    Schweiz Med Wochenschr; 1978 Jun; 108(25):959-62. PubMed ID: 663586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.
    Koshiba H; Minowada J; Pressman D
    J Natl Cancer Inst; 1978 Oct; 61(4):987-91. PubMed ID: 81309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.
    MacLean GD; Seehafer J; Shaw AR; Kieran MW; Longenecker BM
    J Natl Cancer Inst; 1982 Aug; 69(2):357-64. PubMed ID: 6180206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic differences among osteogenic sarcoma tumor cells taken from different locations in human tumors.
    Byers VS; Johnston JO
    Cancer Res; 1977 Sep; 37(9):3173-83. PubMed ID: 69491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukemia-associated antigens: detection on cells of established lymphoblastoid lines.
    Mohanakumar T; Pauly JL; Sokal JE; Metzgar RS
    J Immunol; 1975 Dec; 115(6):1542-8. PubMed ID: 171308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
    Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
    Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
    Wikstrand CJ; Bigner SH; Bigner DD
    Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen.
    Carrel S; Delisle MC; Mach JP
    Cancer Res; 1977 Aug; 37(8 Pt 1):2644-50. PubMed ID: 872092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
    Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
    J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface antigens of human glioma cells shared with normal adult and fetal brain.
    Wikstrand CJ; Bigner DD
    Cancer Res; 1979 Aug; 39(8):3235-43. PubMed ID: 88260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.